This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ola Fjellstrom: Innovator in Recombinant Protein Treatments
Introduction
Ola Fjellstrom is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments. His work focuses on the administration of recombinant proteins in conjunction with specific inhibitors.
Latest Patents
Ola Fjellstrom holds a patent for a groundbreaking invention titled "Combination Treatment by Administering a Recombinant Apyrase Protein in Conjunction with a P2Y12 Inhibitor." This patent represents a significant advancement in therapeutic strategies, potentially improving patient outcomes in various medical conditions.
Career Highlights
Ola is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise to create effective treatment solutions. His innovative approach has garnered attention within the scientific community.
Collaborations
Ola has collaborated with esteemed colleagues, including Leif Carlsson and Sven Nylander. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Ola Fjellstrom's contributions to biotechnology and his innovative patent demonstrate his commitment to advancing medical treatments. His work at AstraZeneca AB and collaborations with fellow researchers highlight the importance of teamwork in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile